84 related articles for article (PubMed ID: 1772671)
1. Global and regional ventricular function following intracoronary application of papaverine.
Schad H; Heimisch W; Haas F; Blasini R; Mendler N
Eur J Cardiothorac Surg; 1991; 5(11):598-602. PubMed ID: 1772671
[TBL] [Abstract][Full Text] [Related]
2. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary papaverine but not adenosine reduces regional ventricular function.
Martin SE; Schmarkey LS; Oh DJ; Patterson RE
Cardiovasc Res; 1993 Nov; 27(11):2028-36. PubMed ID: 8287414
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter.
Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M
Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819
[TBL] [Abstract][Full Text] [Related]
6. Models of coronary artery disease: "critical" versus "functional" coronary artery stenosis.
Schad H; Heimisch W; Mendler N
Thorac Cardiovasc Surg; 1991 Feb; 39(1):13-8. PubMed ID: 2011842
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
Kopia GA; Valocik RE; Torphy TJ; Cieslinksi LB; Sarau HM; Foley JJ; Wasserman MA
J Pharmacol Exp Ther; 1987 Apr; 241(1):174-80. PubMed ID: 2437287
[TBL] [Abstract][Full Text] [Related]
8. [Coronary reserve determination by intracoronary papaverine: effects of various doses on coronary circulation and hemodynamics].
Franz N; Modersohn D; Romaniuk P; Linss G
Z Gesamte Inn Med; 1991; 46(1-2):15-7. PubMed ID: 2038868
[TBL] [Abstract][Full Text] [Related]
9. Torsades de pointes after intracoronary papaverine.
Vrolix M; Piessens J; De Geest H
Eur Heart J; 1991 Feb; 12(2):273-6. PubMed ID: 2044564
[TBL] [Abstract][Full Text] [Related]
10. Investigation on the effect of dipyridamole and papaverine on regional blood flow and cardiac hemodynamics in anesthetized dogs.
Sakanashi M; Noguchi K; Kato T; Matsuzaki T; Kinjo N; Ikema S; Miyagi H; Moromizato H; Nakasone J; Kinjo Y
Arzneimittelforschung; 1989 Sep; 39(9):1119-23. PubMed ID: 2590262
[TBL] [Abstract][Full Text] [Related]
11. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
13. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
14. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
[TBL] [Abstract][Full Text] [Related]
15. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
Kern MJ; Deligonul U; Tatineni S; Serota H; Aguirre F; Hilton TC
J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin increases myocardial contractility: relation to the Gregg phenomenon.
Munch PA; Longhurst JC
Am J Physiol; 1991 Jun; 260(6 Pt 2):R1095-103. PubMed ID: 2058737
[TBL] [Abstract][Full Text] [Related]
17. [Changes in PTCA. A model of ischemia in humans].
Prachar H
Acta Med Austriaca Suppl; 1991; 42():1-35. PubMed ID: 1830715
[TBL] [Abstract][Full Text] [Related]
18. QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine.
Inoue T; Asahi S; Takayanagi K; Morooka S; Takabatake Y
Cardiology; 1994; 84(1):9-13. PubMed ID: 7511988
[TBL] [Abstract][Full Text] [Related]
19. Phasic mitral blood flow and regional left ventricular dimensions: possible mechanism of active assist to ventricular filling.
Bertha BG; Folts JD
Circulation; 1986 Oct; 74(4):901-11. PubMed ID: 3530525
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
Takeuchi M; Nohtomi Y; Kuroiwa A
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
